Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Active Not Recruiting Phase 1 / 2 Trials for Buparlisib (DB11666)

IndicationStatusPhase
DBCOND0029840 (Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01816984PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerTreatment